BERLIN (Reuters) - Investor demand for shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, ...
BERLIN - Investor demand for shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, including the greenshoe option, banks told investors onBERLIN - Investor demand for
shares in the medical vials division of Schott AG exceeds the deal size in its initial public offering, including the greenshoe option, banks told investors on Tuesday, an hour after the start of the subscription period.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Germany’s Schott Seeks €859 Million in IPO of Medical-Glass UnitSchott AG is looking to raise as much as €859 million ($917 million) from an initial public offering of its specialty medical-glassware division, in what is likely to be one of the biggest German stock listings this year.
Lire la suite »
Klaviyo, Instacart raise IPO price rangesAfter Arm Holdings' (ARM) strong IPO debut, Klaviyo (KVYO) raised its IPO price range to between $27 and $29 per share. This comes after Instacart (CART) raised its own IPO price range as well, to between $28 and $30 per share. Yahoo Finance Live discusses what these debuts could mean for the IPO market.
Lire la suite »
India's Torrent Pharma in talks with CVC, Bain Capital for Cipla bid- sourcesBy Aditya Kalra and M. Sriram DELHI/MUMBAI (Reuters) - India's Torrent Pharmaceuticals is in talks with private equity funds CVC Capital Partners and ...
Lire la suite »
60 Degrees Pharma withdraws mid-stage study application for COVID drug(Reuters) - 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration (FDA) for a mid-stage ...
Lire la suite »
60 Degrees Pharma withdraws mid-stage study application for COVID drug(Reuters) - 60 Degrees Pharmaceuticals said on Monday it has withdrawn an application to the U.S. Food and Drug Administration (FDA) for a mid-stage ...
Lire la suite »
Chinese AI firm Fourth Paradigm leads Hong Kong IPO surge to raise $280 millionThree Chinese firms, led by AI software company Beijing Fourth Paradigm, are aiming to raise up to $280 million in Hong Kong initial public offerings launched on Monday. Beijing Fourth Paradigm, an AI startup, is aiming to raise up to $144 million by selling 18.4 million shares in a price range of HK$55.60 to HK$61.16 each, according to its regulatory filings. Three cornerstone investors, headed by New China Capital Management, have subscribed for about $96.8 million worth of stock, which equates to 70.6% of the IPO, the filings showed.
Lire la suite »